Fondren Management’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,333
Closed -$272K 86
2019
Q4
$272K Sell
5,333
-6,579
-55% -$336K 0.28% 75
2019
Q3
$439K Buy
+11,912
New +$439K 0.37% 63